Showing results (31-40 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|February 21, 2014
Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cellsFei Duan, Ming Lin, Chuanyin Li, et al.Cancer Biology & Therapy|October 16, 2009
Identification of beta2-microglobulin as a potential target for ovarian cancerHan Shuo Yang, Yu Li, Hong Xin Deng, et al.Cancer Biology & Therapy|March 19, 2008
Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancerChandramani Pathak, Yogesh K Jaiswal, Manjula VinayakCancer Biology & Therapy|March 19, 2008
Enhancement of p53 gene transfer efficiency in hepatic tumor mediated by transferrin receptor through trans-arterial deliveryQin Lu, Gao-Jun Teng, Yue Zhang, et al.Cancer Biology & Therapy|October 18, 2018
Frontline immunotherapy treatment with nivolumab and ipilimumab in metastatic renal cell cancer: a new standard of careAmanda Nizam, Jeanny B Aragon-ChingCancer Biology & Therapy|October 18, 2018
The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective studyZeran Yang, Guang Chen, Ye Cui, et al.Cancer Biology & Therapy|December 29, 2021
Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivoLaura Patras, Aura Elena Ionescu, Cristian Munteanu, et al.Cancer Biology & Therapy|February 9, 2012
Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitorFan Yang, Veronica Jove, Shirley Chang, et al.Cancer Biology & Therapy|February 9, 2012
Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivityMiyako Takata, Hiroki Chikumi, Naomi Miyake, et al.Cancer Biology & Therapy|February 9, 2012
Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activationJürgen Sonnemann, Navina Trommer, Sabine Becker, et al.Pageof 387